The multifunctional human ocular melanocortin system

[1]  Andrew W. Taylor,et al.  Stimulating the Melanocortin System in Uveitis and Diabetes Preserves the Structure and Anti-Inflammatory Activity of the Retina , 2023, International journal of molecular sciences.

[2]  Yuxiang Du,et al.  Ocular immune privilege and retinal pigment epithelial cells. , 2023, Journal of leukocyte biology.

[3]  U. Greferath,et al.  Exploring the pathogenesis of age-related macular degeneration: A review of the interplay between retinal pigment epithelium dysfunction and the innate immune system , 2022, Frontiers in Neuroscience.

[4]  Trinidad Montero-Melendez,et al.  Translational advances of melanocortin drugs: Integrating biology, chemistry and genetics. , 2022, Seminars in immunology.

[5]  A. Lo,et al.  Anti-inflammatory α-Melanocyte-Stimulating Hormone Protects Retina After Ischemia/Reperfusion Injury in Type I Diabetes , 2022, Frontiers in Neuroscience.

[6]  Andrew W. Taylor,et al.  Melanocortin receptor agonists suppress experimental autoimmune uveitis. , 2022, Experimental eye research.

[7]  H. Agostini,et al.  The Human Eye Transcriptome Atlas: A searchable comparative transcriptome database for healthy and diseased human eye tissue. , 2022, Genomics.

[8]  M. Doğru,et al.  Tear film and ocular surface neuropeptides: Characteristics, synthesis, signaling and implications for ocular surface and systemic diseases. , 2022, Experimental eye research.

[9]  M. Campbell,et al.  The blood–retina barrier in health and disease , 2021, The FEBS journal.

[10]  Zhongmou Sun,et al.  The neuropeptide alpha-melanocyte-stimulating hormone is critical for corneal endothelial cell protection and graft survival after transplantation. , 2021, The American journal of pathology.

[11]  P. Grieco,et al.  Fingolimod and Diabetic Retinopathy: A Drug Repurposing Study , 2021, Frontiers in Pharmacology.

[12]  C. Goding,et al.  MC1R Functions, Expression, and Implications for Targeted Therapy. , 2021, The Journal of investigative dermatology.

[13]  Evan S. Glazer,et al.  The Sex Differences in Uveal Melanoma: Potential Roles of EIF1AX, Immune Response and Redox Regulation , 2021, Current oncology.

[14]  P. Bhat,et al.  Publication bias, Open-Labeled Trials and Sky Rocketing Costs- Past, Present and Future of Repository Corticotropin Injection? , 2021, Ocular immunology and inflammation.

[15]  Shaozhen Zhao,et al.  α-MSH ameliorates corneal surface dysfunction in scopolamine-induced dry eye rats and human corneal epithelial cells via enhancing EGFR expression. , 2021, Experimental eye research.

[16]  Adam P. DeLuca,et al.  Exome-based investigation of the genetic basis of human pigmentary glaucoma , 2021, BMC Genomics.

[17]  Dimple Nagpal,et al.  A review of diabetic retinopathy: Datasets, approaches, evaluation metrics and future trends , 2021, J. King Saud Univ. Comput. Inf. Sci..

[18]  T. Wong,et al.  Global Prevalence of Diabetic Retinopathy and Projection of Burden through 2045: Systematic Review and Meta-analysis. , 2021, Ophthalmology.

[19]  M. Madigan,et al.  The role of melanocytes in the human choroidal microenvironment and inflammation: Insights from the transcriptome , 2021, Pigment cell & melanoma research.

[20]  Theodore Leng,et al.  Management of repository corticotropin injection therapy for non‐infectious uveitis: a Delphi study , 2021, Acta ophthalmologica.

[21]  Andrew W. Taylor,et al.  Melanocortin 5 Receptor Expression and Recovery of Ocular Immune Privilege after Uveitis , 2021, Ocular immunology and inflammation.

[22]  Shaozhen Zhao,et al.  A combination of CMC and α-MSH inhibited ROS activated NLRP3 inflammasome in hyperosmolarity stressed HCECs and scopolamine-induced dry eye rats , 2021, Scientific reports.

[23]  A. Catania,et al.  Activation of Melanocortin Receptors as a Potential Strategy to Reduce Local and Systemic Reactions Induced by Respiratory Viruses , 2020, Frontiers in Endocrinology.

[24]  M. Halasi,et al.  Melanocytes determine angiogenesis gene expression across human tissues , 2020, bioRxiv.

[25]  J. Mehta,et al.  Corneal endothelial dysfunction: Evolving understanding and treatment options , 2020, Progress in Retinal and Eye Research.

[26]  E. Moros,et al.  Biodistribution and Multi-Compartment Pharmacokinetic Analysis of a Targeted Alpha Particle Therapy. , 2020, Molecular pharmaceutics.

[27]  Zhongmou Sun,et al.  Association of α-Melanocyte-Stimulating Hormone With Corneal Endothelial Cell Survival During Oxidative Stress and Inflammation-Induced Cell Loss in Donor Tissue. , 2020, JAMA ophthalmology.

[28]  C. Lange,et al.  Transcriptional Profiling Uncovers Human Hyalocytes as a Unique Innate Immune Cell Population , 2020, Frontiers in Immunology.

[29]  Alexander B Crane,et al.  Use of Adrenocorticotropic Hormone in Ophthalmology. , 2020, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[30]  R. Insall,et al.  Melanoblasts Populate the Mouse Choroid Earlier in Development Than Previously Described , 2020, Investigative ophthalmology & visual science.

[31]  J. Mehta,et al.  Evolution of therapies for the corneal endothelium: past, present and future approaches , 2020, British Journal of Ophthalmology.

[32]  P. Mitchell,et al.  Anti-vascular endothelial growth factor in neovascular age-related macular degeneration – a systematic review of the impact of anti-VEGF on patient outcomes and healthcare systems , 2020, BMC Ophthalmology.

[33]  Caroline L. Smith,et al.  Emerging roles of melanocortin receptor accessory proteins (MRAP and MRAP2) in physiology and pathophysiology. , 2020, Gene.

[34]  C. Llanos,et al.  New Pharmacological Strategies for the Treatment of Non-Infectious Uveitis. A Minireview , 2020, Frontiers in Pharmacology.

[35]  C. Shields,et al.  Uveal melanoma , 2020, Nature Reviews Disease Primers.

[36]  R. Gong,et al.  Melanocortin 5 receptor signaling pathway in health and disease , 2020, Cellular and Molecular Life Sciences.

[37]  R. Furie,et al.  Acthar Gel (repository corticotropin injection) for persistently active SLE: study design and baseline characteristics from a multicentre, randomised, double-blind, placebo-controlled trial , 2020, Lupus Science & Medicine.

[38]  U. Singh,et al.  The Role of PVN MC4R Neural Pathway in Autonomic Control of Metabolic Homeostasis and Cardiovascular Function , 2020, The FASEB Journal.

[39]  M. Lin,et al.  The Immunological Basis of Dry Eye Disease and Current Topical Treatment Options , 2020, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[40]  J. Wernberg,et al.  Epidemiology and Risk Factors of Melanoma. , 2020, The Surgical clinics of North America.

[41]  S. Schwartz,et al.  Diabetic Retinopathy–An Underdiagnosed and Undertreated Inflammatory, Neuro-Vascular Complication of Diabetes , 2019, Front. Endocrinol..

[42]  E. Gratton,et al.  Shedding light on melanins within in situ human eye melanocytes using 2-photon microscopy profiling techniques , 2019, Scientific Reports.

[43]  Hongguang Lu,et al.  Opsin3 Downregulation Induces Apoptosis of Human Epidermal Melanocytes via Mitochondrial Pathway , 2019, Photochemistry and photobiology.

[44]  Y. Tao,et al.  Melanocortin Regulation of Inflammation , 2019, Front. Endocrinol..

[45]  R. Scharfmann,et al.  Loss-of-function mutations in MRAP2 are pathogenic in hyperphagic obesity with hyperglycemia and hypertension , 2019, Nature Medicine.

[46]  Andrew W. Taylor,et al.  Recovery of ocular immune privilege after uveitis requires melanocortin 5 receptor expression , 2019 .

[47]  R. Cimaz,et al.  Evidence-Based Treatment for Uveitis. , 2019, The Israel Medical Association journal : IMAJ.

[48]  D. Chu,et al.  Adrenocorticotropic hormone gel for patients with non-infectious uveitis , 2019, American journal of ophthalmology case reports.

[49]  D. Oprian,et al.  Human nonvisual opsin 3 regulates pigmentation of epidermal melanocytes through functional interaction with melanocortin 1 receptor , 2019, Proceedings of the National Academy of Sciences.

[50]  A. Thomas.  Biologics for the treatment of noninfectious uveitis: current concepts and emerging therapeutics , 2019, Current opinion in ophthalmology.

[51]  W. Nelson,et al.  Retrospective Medical Record Review to Describe Use of Repository Corticotropin Injection Among Patients with Uveitis in the United States , 2019, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[52]  Rutao Cui,et al.  Targeting MC1R depalmitoylation to prevent melanomagenesis in redheads , 2019, Nature Communications.

[53]  F. J. Romero,et al.  ARPE-19-derived VEGF-containing exosomes promote neovascularization in HUVEC: the role of the melanocortin receptor 5 , 2019, Cell cycle.

[54]  E. Moros,et al.  Melanocortin 1 Receptor–Targeted α-Particle Therapy for Metastatic Uveal Melanoma , 2019, The Journal of Nuclear Medicine.

[55]  C. Spana,et al.  Probing the Role of Melanocortin Type 1 Receptor Agonists in Diverse Immunological Diseases , 2019, Front. Pharmacol..

[56]  M. Labetoulle,et al.  Classifying signs and symptoms of dry eye disease according to underlying mechanism via the Delphi method: the DIDACTIC study , 2019, British Journal of Ophthalmology.

[57]  B. Gelfand,et al.  RF/6A Chorioretinal Cells Do Not Display Key Endothelial Phenotypes , 2018, Investigative ophthalmology & visual science.

[58]  R. Sergott,et al.  Melanocortin in the Pathogenesis of Inflammatory Eye Diseases: Considerations for Treatment. , 2018, Retina.

[59]  Keun-Chang Kwak,et al.  Zerumbone, a Tropical Ginger Sesquiterpene of Zingiber officinale Roscoe, Attenuates α-MSH-Induced Melanogenesis in B16F10 Cells , 2018, International journal of molecular sciences.

[60]  A. Coll,et al.  POMC: The Physiological Power of Hormone Processing. , 2018, Physiological reviews.

[61]  M. Labetoulle,et al.  Role of corneal nerves in ocular surface homeostasis and disease , 2018, Acta ophthalmologica.

[62]  Rishi P. Singh,et al.  The role of anti-vascular endothelial growth factor (anti-VEGF) in the management of proliferative diabetic retinopathy , 2018, Drugs in context.

[63]  Wei Wang,et al.  Diabetic Retinopathy: Pathophysiology and Treatments , 2018, International journal of molecular sciences.

[64]  S. Sugita,et al.  Immune Privilege and Eye-Derived T-Regulatory Cells , 2018, Journal of immunology research.

[65]  K. Suk,et al.  Phytochemicals as modulators of M1-M2 macrophages in inflammation , 2018, Oncotarget.

[66]  M. Meldal,et al.  MC4R Agonists: Structural Overview on Antiobesity Therapeutics. , 2018, Trends in pharmacological sciences.

[67]  D. Chu,et al.  Adrenocorticotropic hormone analogue as novel treatment regimen in ocular cicatricial pemphigoid , 2018, American journal of ophthalmology case reports.

[68]  R. Wei,et al.  Α-Melanocyte-Stimulating Hormone Protects Early Diabetic Retina from Blood-Retinal Barrier Breakdown and Vascular Leakage via MC4R , 2018, Cellular Physiology and Biochemistry.

[69]  Yu-Ying He,et al.  Mechanisms and prevention of UV‐induced melanoma , 2018, Photodermatology, photoimmunology & photomedicine.

[70]  C. Chiquet,et al.  Uveitis: Diagnostic work-up. A literature review and recommendations from an expert committee. , 2017, Autoimmunity reviews.

[71]  Mark D. Ericson,et al.  Bench-top to clinical therapies: A review of melanocortin ligands from 1954 to 2016. , 2017, Biochimica et biophysica acta. Molecular basis of disease.

[72]  J. García-Borrón,et al.  MC1R signaling. Intracellular partners and pathophysiological implications. , 2017, Biochimica et biophysica acta. Molecular basis of disease.

[73]  Jennifer K. Sun,et al.  Diabetic retinopathy: current understanding, mechanisms, and treatment strategies. , 2017, JCI insight.

[74]  K. Tsubota,et al.  TFOS DEWS II Definition and Classification Report. , 2017, The ocular surface.

[75]  D. Schaumberg,et al.  TFOS DEWS II Epidemiology Report. , 2017, The ocular surface.

[76]  J. Wikberg,et al.  Melanocortin 2, 3 and 4 Receptor Gene Expressions are Downregulated in CD8+ T Cytotoxic Lymphocytes and CD19+ B Lymphocytes in Rheumatoid Arthritis Responding to TNF‐α Inhibition , 2017, Scandinavian journal of immunology.

[77]  P. Grieco,et al.  Melanocortin receptor agonists MCR 1‐5 protect photoreceptors from high‐glucose damage and restore antioxidant enzymes in primary retinal cell culture , 2016, Journal of cellular and molecular medicine.

[78]  C. Cursiefen,et al.  Identification of Novel Endogenous Anti(lymph)angiogenic Factors in the Aqueous Humor. , 2016, Investigative ophthalmology & visual science.

[79]  C. Foster,et al.  MC5r and A2Ar Deficiencies During Experimental Autoimmune Uveitis Identifies Distinct T cell Polarization Programs and a Biphasic Regulatory Response , 2016, Scientific Reports.

[80]  Alan N. Brown.  Repository corticotropin injection in patients with refractory psoriatic arthritis: a case series , 2016, Open access rheumatology : research and reviews.

[81]  Q. Nguyen,et al.  Subcutaneous repository corticotropin gel for non-infectious panuveitis: Reappraisal of an old pharmacologic agent , 2016, American journal of ophthalmology case reports.

[82]  N. Bressler,et al.  Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema: Two-Year Results from a Comparative Effectiveness Randomized Clinical Trial. , 2016, Ophthalmology.

[83]  A. Clark.  60 YEARS OF POMC: The proopiomelanocortin gene: discovery, deletion and disease. , 2016, Journal of molecular endocrinology.

[84]  J. Drouin.  60 YEARS OF POMC: Transcriptional and epigenetic regulation of POMC gene expression. , 2016, Journal of molecular endocrinology.

[85]  C. Clemson,et al.  The Role of Alpha-MSH as a Modulator of Ocular Immunobiology Exemplifies Mechanistic Differences between Melanocortins and Steroids , 2016, Ocular immunology and inflammation.

[86]  P. Grieco,et al.  Activation of Melanocortin Receptors MC1 and MC5 Attenuates Retinal Damage in Experimental Diabetic Retinopathy , 2016, Mediators of inflammation.

[87]  R. Wei,et al.  α-Melanocyte-stimulating hormone ameliorates ocular surface dysfunctions and lesions in a scopolamine-induced dry eye model via PKA-CREB and MEK-Erk pathways , 2015, Scientific Reports.

[88]  R. Baughman,et al.  Sarcoidosis patient with lupus pernio and infliximab-induced myositis: Response to Acthar gel , 2015, Respiratory medicine case reports.

[89]  G. Macfarlane,et al.  Non-anti-TNF biologic modifier drugs in non-infectious refractory chronic uveitis: The current evidence from a systematic review. , 2015, Seminars in arthritis and rheumatism.

[90]  Trinidad Montero-Melendez,et al.  ACTH: The forgotten therapy. , 2015, Seminars in immunology.

[91]  M. Perretti,et al.  Biased Agonism as a Novel Strategy To Harness the Proresolving Properties of Melanocortin Receptors without Eliciting Melanogenic Effects , 2015, The Journal of Immunology.

[92]  A. Madan.  Repository corticotropin injection in a patient presenting with focal segmental glomerulosclerosis, rheumatoid arthritis, and optic neuritis: a case report , 2015, International journal of general medicine.

[93]  R. D'Amato,et al.  Melanocyte pigmentation inversely correlates with MCP‐1 production and angiogenesis‐inducing potential , 2015, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[94]  S. Whitcup,et al.  Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema. , 2014, Ophthalmology.

[95]  G. Z. Rocha,et al.  Hypothalamic S1P/S1PR1 axis controls energy homeostasis , 2014, Nature Communications.

[96]  Shuanggang Hu,et al.  Transcriptomic changes during the pre-receptive to receptive transition in human endometrium detected by RNA-Seq. , 2014, The Journal of clinical endocrinology and metabolism.

[97]  L. Rizzolo.  Barrier properties of cultured retinal pigment epithelium. , 2014, Experimental eye research.

[98]  M. Socha,et al.  A preliminary evaluation of VEGF-A, VEGFR1 and VEGFR2 in patients with well-controlled type 2 diabetes mellitus , 2014, Journal of Zhejiang University-SCIENCE B.

[99]  Lijie Dong,et al.  α-Melanocyte-Stimulating Hormone Protects Retinal Vascular Endothelial Cells from Oxidative Stress and Apoptosis in a Rat Model of Diabetes , 2014, PloS one.

[100]  Ian Y. Wong,et al.  Ocular Anti-VEGF Therapy for Diabetic Retinopathy: Overview of Clinical Efficacy and Evolving Applications , 2014, Diabetes Care.

[101]  R. V. Van Gelder,et al.  Expert panel recommendations for the use of anti-tumor necrosis factor biologic agents in patients with ocular inflammatory disorders. , 2014, Ophthalmology.

[102]  Jin Yao,et al.  Alpha-melanocyte stimulating hormone protects retinal pigment epithelium cells from oxidative stress through activation of melanocortin 1 receptor-Akt-mTOR signaling. , 2014, Biochemical and biophysical research communications.

[103]  R. D'Amato,et al.  Melanocyte-secreted fibromodulin promotes an angiogenic microenvironment. , 2014, The Journal of clinical investigation.

[104]  K. Tsubota,et al.  Changing trends in the treatment of dry-eye disease , 2013, Expert opinion on investigational drugs.

[105]  R. Ašoklis,et al.  Clinical Interventions in Aging Dovepress Age-related Changes in Corneal Thickness and Endothelial Characteristics Saulius Galgauskas Dovile ˙ Norvydaite ˙ , 2022 .

[106]  M. Ridderstråle,et al.  Loss of Function of the Melanocortin 2 Receptor Accessory Protein 2 Is Associated with Mammalian Obesity , 2013, Science.

[107]  S. Amrock,et al.  Diverging Racial Trends in Neonatal Infantile Hemangioma Diagnoses, 1979–2006 , 2013, Pediatric dermatology.

[108]  Aziz A. Khanifar,et al.  Age-related macular degeneration: choroidal ischaemia? , 2013, British Journal of Ophthalmology.

[109]  Mechthild Prinz,et al.  Improved eye- and skin-color prediction based on 8 SNPs , 2013, Croatian medical journal.

[110]  R. Schlingemann,et al.  Molecular basis of the inner blood-retinal barrier and its breakdown in diabetic macular edema and other pathological conditions , 2013, Progress in Retinal and Eye Research.

[111]  F. Bandello,et al.  Review on the Worldwide Epidemiology of Uveitis , 2013, European journal of ophthalmology.

[112]  M. Zaidi,et al.  Mechanisms of action of adrenocorticotropic hormone and other melanocortins relevant to the clinical management of patients with multiple sclerosis , 2013, Multiple sclerosis.

[113]  P. Campochiaro,et al.  Sustained delivery fluocinolone acetonide vitreous inserts provide benefit for at least 3 years in patients with diabetic macular edema. , 2012, Ophthalmology.

[114]  S. Grässel,et al.  Role of proopiomelanocortin-derived peptides and their receptors in the osteoarticular system: from basic to translational research. , 2012, Endocrine reviews.

[115]  Ingrid U. Scott,et al.  Anti-VEGF Treatment Strategies for Wet AMD , 2012, Journal of ophthalmology.

[116]  Sanket U. Shah,et al.  Iris melanoma: features and prognosis in 317 children and adults. , 2012, Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus.

[117]  Y. Le,et al.  RPE barrier breakdown in diabetic retinopathy: seeing is believing , 2011, Journal of ocular biology, diseases, and informatics.

[118]  A. Stratigos,et al.  Melanocortin 1 Receptor Variants: Functional Role and Pigmentary Associations , 2011, Photochemistry and photobiology.

[119]  B. Nan,et al.  Racial differences in age-related macular degeneration rates in the United States: a longitudinal analysis of a managed care network. , 2011, American journal of ophthalmology.

[120]  J. Kaplan,et al.  Immunosuppressive activity of a novel peptide analog of alpha-melanocyte stimulating hormone (α-MSH) in experimental autoimmune uveitis , 2011, Journal of Neuroimmunology.

[121]  W. Millard,et al.  Implication of the melanocortin-3 receptor in the regulation of food intake. , 2011, European journal of pharmacology.

[122]  A. Rudensky,et al.  Interleukin-10 signaling in regulatory T cells is required for suppression of Th17 cell-mediated inflammation. , 2011, Immunity.

[123]  Z. Abdel‐Malek,et al.  Signaling from the human melanocortin 1 receptor to ERK1 and ERK2 mitogen-activated protein kinases involves transactivation of cKIT. , 2011, Molecular endocrinology.

[124]  Andrew W. Taylor,et al.  Localized retinal neuropeptide regulation of macrophage and microglial cell functionality , 2011, Journal of Neuroimmunology.

[125]  A. Clark,et al.  Melanocortin receptors and their accessory proteins , 2011, Molecular and Cellular Endocrinology.

[126]  J. Cunha-Vaz,et al.  Blood-Retinal Barrier , 2011, European journal of ophthalmology.

[127]  A. Catania,et al.  The Melanocortin System in Control of Inflammation , 2010, TheScientificWorldJournal.

[128]  P. Déchelotte,et al.  Psychopathological and personality features in primary Sjogren's syndrome--associations with autoantibodies to neuropeptides. , 2010, Rheumatology.

[129]  S. Vinores.  Breakdown of the Blood–Retinal Barrier , 2010, Encyclopedia of the Eye.

[130]  D. Azar,et al.  Novel aspects of corneal angiogenic and lymphangiogenic privilege , 2010, Progress in Retinal and Eye Research.

[131]  Ludwig Kappos,et al.  Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis. , 2010, The New England journal of medicine.

[132]  F. Gruber,et al.  MC1R Gene Polymorphism Affects Skin Color and Phenotypic Features Related to Sun Sensitivity in a Population of French Adult Women , 2009, Photochemistry and photobiology.

[133]  L. Aiello,et al.  Activation of PKC-δ and SHP-1 by hyperglycemia causes vascular cell apoptosis and diabetic retinopathy , 2009, Nature Medicine.

[134]  T. Luger,et al.  The melanocortin system in articular chondrocytes: melanocortin receptors, pro-opiomelanocortin, precursor proteases, and a regulatory effect of alpha-melanocyte-stimulating hormone on proinflammatory cytokines and extracellular matrix components. , 2009, Arthritis and rheumatism.

[135]  K. Ballmer-Hofer,et al.  Structure and function of VEGF receptors , 2009, IUBMB life.

[136]  Darren J. Lee,et al.  Injection of an alpha-melanocyte stimulating hormone expression plasmid is effective in suppressing experimental autoimmune uveitis. , 2009, International immunopharmacology.

[137]  P. M. Hinkle,et al.  Opposite Effects of the Melanocortin-2 (MC2) Receptor Accessory Protein MRAP on MC2 and MC5 Receptor Dimerization and Trafficking* , 2009, The Journal of Biological Chemistry.

[138]  H. Aburatani,et al.  T-cell suppression by programmed cell death 1 ligand 1 on retinal pigment epithelium during inflammatory conditions. , 2009, Investigative ophthalmology & visual science.

[139]  M. Elphick,et al.  MRAP and MRAP2 are bidirectional regulators of the melanocortin receptor family , 2009, Proceedings of the National Academy of Sciences.

[140]  K. Schallreuter,et al.  Regulation of pigmentation in human epidermal melanocytes by functional high-affinity beta-melanocyte-stimulating hormone/melanocortin-4 receptor signaling. , 2009, Endocrinology.

[141]  T. Webb,et al.  Distinct melanocortin 2 receptor accessory protein domains are required for melanocortin 2 receptor interaction and promotion of receptor trafficking. , 2009, Endocrinology.

[142]  A. Taylor.  Ocular immune privilege , 2009, Eye.

[143]  P. Grieco,et al.  A role for MC3R in modulating lung inflammation. , 2008, Pulmonary pharmacology & therapeutics.

[144]  L. Debeljuk,et al.  Role of α-melanocyte stimulating hormone and melanocortin 4 receptor in brain inflammation , 2008, Peptides.

[145]  Dayu Li,et al.  Diminishment of α‐MSH anti‐inflammatory activity in MC1r siRNA‐transfected RAW264.7 macrophages , 2008, Journal of leukocyte biology.

[146]  F. Sera,et al.  MC1R variants, melanoma and red hair color phenotype: A meta‐analysis , 2008, International journal of cancer.

[147]  E. Chi,et al.  Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces. , 2008, Immunity.

[148]  Y. Iwakura,et al.  Melanocortin 2 receptor is required for adrenal gland development, steroidogenesis, and neonatal gluconeogenesis , 2007, Proceedings of the National Academy of Sciences.

[149]  H. Schiöth,et al.  Activation of melanocortin 4 receptors reduces the inflammatory response and prevents apoptosis induced by lipopolysaccharide and interferon-gamma in astrocytes. , 2007, Endocrinology.

[150]  Guangyu Wu,et al.  Regulation of G protein-coupled receptor export trafficking. , 2007, Biochimica et biophysica acta.

[151]  R. Kiessling,et al.  Melanocortin 1 receptor is expressed by uveal malignant melanoma and can be considered a new target for diagnosis and immunotherapy. , 2007, Investigative ophthalmology & visual science.

[152]  M. Mulholland,et al.  Melanocortin-3 receptor activates MAP kinase via PI3 kinase , 2007, Regulatory Peptides.

[153]  M. Mulholland,et al.  Melanocortin-4 receptor-mediated inhibition of apoptosis in immortalized hypothalamic neurons via mitogen-activated protein kinase , 2006, Peptides.

[154]  D. Hu,et al.  Uveal Melanocytes Do Not Respond To or Express Receptors for α-Melanocyte-Stimulating Hormone , 2006 .

[155]  N Kitaichi,et al.  Melanocortin 5 receptor and ocular immunity. , 2006, Cellular and molecular biology.

[156]  R. Cone.  Studies on the physiological functions of the melanocortin system. , 2006, Endocrine reviews.

[157]  J. García-Borrón,et al.  Melanocortin-1 receptor structure and functional regulation. , 2005, Pigment cell research.

[158]  Helgi B. Schiöth,et al.  Evolutionary conservation of the structural, pharmacological, and genomic characteristics of the melanocortin receptor subtypes , 2005, Peptides.

[159]  Y. Hayasaka,et al.  Effect of Alpha-Melanocyte-Stimulating Hormone on Interleukin 8 and Monocyte Chemotactic Protein 1 Expression in a Human Retinal Pigment Epithelial Cell Line , 2005, Ophthalmic Research.

[160]  Douglas A Jabs,et al.  Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. , 2005, American journal of ophthalmology.

[161]  R. Cone.  Anatomy and regulation of the central melanocortin system , 2005, Nature Neuroscience.

[162]  D. Sessler,et al.  Increased Sensitivity to Thermal Pain and Reduced Subcutaneous Lidocaine Efficacy in Redheads , 2005, Anesthesiology.

[163]  H. Schiöth,et al.  Pharmacological characterization of loss of function mutations of the human melanocortin 1 receptor that are associated with red hair. , 2004, The Journal of investigative dermatology.

[164]  Hiroshi Toshida,et al.  Microarray analysis of the rat lacrimal gland following the loss of parasympathetic control of secretion. , 2004, Physiological genomics.

[165]  P. Kanetsky,et al.  Population differences in the frequency of the agouti signaling protein g.8818a>G polymorphism. , 2004, Pigment cell research.

[166]  J. M. Lipton,et al.  Targeting Melanocortin Receptors as a Novel Strategy to Control Inflammation , 2004, Pharmacological Reviews.

[167]  F. Hallböök,et al.  Proopiomelanocortin and melanocortin receptors in the adult rat retino-tectal system and their regulation after optic nerve transection. , 2003, European journal of pharmacology.

[168]  D. Easton,et al.  Role of MC1R variants in uveal melanoma , 2003, British Journal of Cancer.

[169]  N. Naveh.  Melanocortins applied intravitreally delay retinal dystrophy in Royal College of Surgeons rats , 2003, Graefe's Archive for Clinical and Experimental Ophthalmology.

[170]  A. Daal,et al.  Melanocortins and their receptors and antagonists. , 2003, Current drug targets.

[171]  S. Sugita,et al.  Iris Pigment Epithelium Expressing CD86 (B7-2) Directly Suppresses T Cell Activation In Vitro via Binding to Cytotoxic T Lymphocyte–associated Antigen 4 , 2003, The Journal of experimental medicine.

[172]  Armin Braun,et al.  α-Melanocyte-Stimulating Hormone Inhibits Allergic Airway Inflammation1 , 2003, The Journal of Immunology.

[173]  Tim Cheetham,et al.  Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene. , 2003, The New England journal of medicine.

[174]  H. Schiöth,et al.  Redundancy of a Functional Melanocortin 1 Receptor in the Anti-inflammatory Actions of Melanocortin Peptides: Studies in the Recessive Yellow (e/e) Mouse Suggest an Important Role for Melanocortin 3 Receptor1 , 2003, The Journal of Immunology.

[175]  I. Gantz,et al.  The melanocortin system. , 2003, American journal of physiology. Endocrinology and metabolism.

[176]  H. Kaplan,et al.  Tolerance is dependent on complement C3 fragment iC3b binding to antigen-presenting cells , 2003, Nature Medicine.

[177]  J. Streilein,et al.  Participation of pigment epithelium in ocular immune privilege. 3. Epithelia cultured from iris, ciliary body, and retina suppress T-cell activation by partially non-overlapping mechanisms , 2003, Ocular immunology and inflammation.

[178]  J. Haycock,et al.  Loss-of-function variants of the human melanocortin-1 receptor gene in melanoma cells define structural determinants of receptor function. , 2002, European journal of biochemistry.

[179]  K. Namba,et al.  Induction of regulatory T cells by the immunomodulating cytokines α‐melanocyte‐stimulating hormone and transforming growth factor‐β2 , 2002, Journal of Leukocyte Biology.

[180]  D. Sliney.  How Light Reaches the Eye and Its Components , 2002, International journal of toxicology.

[181]  Dan-Ning Hu,et al.  Mechanism and clinical significance of prostaglandin-induced iris pigmentation. , 2002, Survey of ophthalmology.

[182]  Robin Holmes,et al.  A polymorphism in the agouti signaling protein gene is associated with human pigmentation. , 2002, American journal of human genetics.

[183]  A. van Daal,et al.  Agouti: from mouse to man, from skin to fat. , 2002, Pigment cell research.

[184]  J. Keunen,et al.  Characterization of melanocortin-1 receptor gene variants in uveal melanoma patients. , 2001, Investigative ophthalmology & visual science.

[185]  J. Haycock,et al.  Cellular and hormonal regulation of pigmentation in human ocular melanocytes. , 2001, Pigment cell research.

[186]  K. Namba,et al.  In vitro induction of CD25+ CD4+ regulatory T cells by the neuropeptide alpha‐melanocyte stimulating hormone (α‐MSH) , 2001, Immunology and cell biology.

[187]  M. Perretti,et al.  Natural and synthetic agonists of the melanocortin receptor type 3 possess anti‐inflammatory properties , 2001, Journal of leukocyte biology.

[188]  J Lindblom,et al.  New aspects on the melanocortins and their receptors. , 2000, Pharmacological research.

[189]  R. Cone,et al.  A Unique Metalolic Sysdrone Causes Obesity in the Melanocortin-3 Receptor-Deficient Mouse. , 2000, Endocrinology.

[190]  Yue Feng,et al.  Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass , 2000, Nature Genetics.

[191]  R. Cone,et al.  Agouti and Agouti-related Protein: Analogies and Contrasts* , 2000, The Journal of Biological Chemistry.

[192]  J. M. Lipton,et al.  Inhibition of peripheral NF-κB activation by central action of α-melanocyte-stimulating hormone , 1999, Journal of Neuroimmunology.

[193]  T. Luger,et al.  Expression of MC1‐ and MC5‐Receptors on the Human Mast Cell Line HMC‐1 , 1999, Annals of the New York Academy of Sciences.

[194]  M. Perretti,et al.  POMC gene-derived peptides activate melanocortin type 3 receptor on murine macrophages, suppress cytokine release, and inhibit neutrophil migration in acute experimental inflammation. , 1999, Journal of immunology.

[195]  J. M. Lipton,et al.  α-MSH and its receptors in regulation of tumor necrosis factor-α production by human monocyte/macrophages. , 1999, American Journal of Physiology. Regulatory Integrative and Comparative Physiology.

[196]  J. Wikberg,et al.  Discovery of a novel superpotent and selective melanocortin-4 receptor antagonist (HS024): evaluation in vitro and in vivo. , 1998, Endocrinology.

[197]  S. Manna,et al.  α-Melanocyte-Stimulating Hormone Inhibits the Nuclear Transcription Factor NF-κB Activation Induced by Various Inflammatory Agents , 1998, The Journal of Immunology.

[198]  D. Fisher,et al.  Involvement of Microphthalmia in the Inhibition of Melanocyte Lineage Differentiation and of Melanogenesis by Agouti Signal Protein* , 1998, The Journal of Biological Chemistry.

[199]  J. Burbach,et al.  Expression of melanocortin-5 receptor in secretory epithelia supports a functional role in exocrine and endocrine glands. , 1998, Endocrinology.

[200]  J. Buggy.  Binding of alpha-melanocyte-stimulating hormone to its G-protein-coupled receptor on B-lymphocytes activates the Jak/STAT pathway. , 1998, The Biochemical journal.

[201]  Ximena Opitz-Araya,et al.  Exocrine Gland Dysfunction in MC5-R-Deficient Mice: Evidence for Coordinated Regulation of Exocrine Gland Function by Melanocortin Peptides , 1997, Cell.

[202]  J. Ortego,et al.  Molecular Characterization and Differential Gene Induction of the Neuroendocrine‐Specific Genes Neurotensin, Neurotensin Receptor, PC1, PC2, and 7B2 in the Human Ocular Ciliary Epithelium , 1997, Journal of neurochemistry.

[203]  G. Barsh,et al.  Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein. , 1997, Science.

[204]  W. Wilkison,et al.  Linkage and Association Studies between the Melanocortin Receptors 4 and 5 Genes and Obesity-Related Phenotypes in the Québec Family Study , 1997, Molecular medicine.

[205]  J. Wikberg,et al.  The melanocortin 1, 3, 4 or 5 receptors do not have a binding epitope for ACTH beyond the sequence of alpha-MSH. , 1997, The Journal of endocrinology.

[206]  J. Streilein,et al.  Aqueous humor induces transforming growth factor-beta (TGF-beta)-producing regulatory T-cells. , 1997, Current eye research.

[207]  M. Tota,et al.  ART (protein product of agouti-related transcript) as an antagonist of MC-3 and MC-4 receptors. , 1997, Biochemical and biophysical research communications.

[208]  G. Barsh,et al.  Agouti signaling protein inhibits melanogenesis and the response of human melanocytes to alpha-melanotropin. , 1997, The Journal of investigative dermatology.

[209]  J. Shutter,et al.  Hypothalamic expression of ART, a novel gene related to agouti, is up-regulated in obese and diabetic mutant mice. , 1997, Genes & development.

[210]  G. Barsh,et al.  Effects of recombinant agouti-signaling protein on melanocortin action. , 1997, Molecular endocrinology.

[211]  J Stjernschantz,et al.  The incidence and time-course of latanoprost-induced iridial pigmentation as a function of eye color. , 1997, Survey of ophthalmology.

[212]  D. Green,et al.  Fas Ligand-Induced Apoptosis as a Mechanism of Immune Privilege , 1995, Science.

[213]  Ian Jackson,et al.  Variants of the melanocyte–stimulating hormone receptor gene are associated with red hair and fair skin in humans , 1995, Nature Genetics.

[214]  A. Genazzani,et al.  Expression of pro-opiomelanocortin gene in human ovarian tissue. , 1995, Human reproduction.

[215]  D. Hu,et al.  Melanogenesis by human uveal melanocytes in vitro. , 1995, Investigative ophthalmology & visual science.

[216]  G. Barsh,et al.  Structure and function of ASP, the human homolog of the mouse agouti gene. , 1995, Human molecular genetics.

[217]  M. Parmentier,et al.  Molecular cloning of a mouse melanocortin 5 receptor gene widely expressed in peripheral tissues. , 1994, Biochemistry.

[218]  S. Macneil,et al.  Effect of melanocyte stimulating hormone on human cultured choroidal melanocytes, uveal melanoma cells, and retinal epithelial cells. , 1994, Investigative ophthalmology & visual science.

[219]  R. Ritch,et al.  Studies of human uveal melanocytes in vitro: isolation, purification and cultivation of human uveal melanocytes. , 1993, Investigative ophthalmology & visual science.

[220]  M. Mortrud,et al.  Cloning and Functional Characterization of a Family of Receptors for the Melanotropic Peptides , 1993, Annals of the New York Academy of Sciences.

[221]  S. Cousins,et al.  Identification of alpha-melanocyte stimulating hormone as a potential immunosuppressive factor in aqueous humor. , 1992, Current eye research.

[222]  M. Mortrud,et al.  The cloning of a family of genes that encode the melanocortin receptors. , 1992, Science.

[223]  V. Hearing,et al.  Enzymatic control of pigmentation in mammals , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[224]  W. Nicholson,et al.  Proopiomelanocortin gene is expressed in many normal human tissues and in tumors not associated with ectopic adrenocorticotropin syndrome. , 1988, Molecular endocrinology.

[225]  R. Boissy.  The melanocyte. Its structure, function, and subpopulations in skin, eyes, and hair. , 1988, Dermatologic clinics.

[226]  M. Welch,et al.  Adrenocorticotropic hormone stimulation of lacrimal peroxidase secretion. , 1987, Experimental eye research.

[227]  H. Söling,et al.  Adrenocorticotropic hormone and alpha-melanocyte-stimulating hormone induce secretion and protein phosphorylation in the rat lacrimal gland by activation of a cAMP-dependent pathway. , 1982, European journal of biochemistry.

[228]  J. Landon.  Adrenocorticotrophin , 1968, Journal of the Royal College of Physicians of London.

[229]  D. Musch,et al.  Dry Eye Syndrome Preferred Practice Pattern®. , 2019, Ophthalmology.

[230]  S. Rocchi,et al.  Melanocytes Sense Blue Light and Regulate Pigmentation through Opsin-3. , 2018, The Journal of investigative dermatology.

[231]  R. Avery,et al.  Systemic Safety of Prolonged Monthly Anti-Vascular Endothelial Growth Factor Therapy for Diabetic Macular Edema: A Systematic Review and Meta-analysis. , 2016, JAMA ophthalmology.

[232]  R. Baughman,et al.  A retrospective pilot study examining the use of Acthar gel in sarcoidosis patients. , 2016, Respiratory medicine.

[233]  L. Timares,et al.  MC1R, Eumelanin and Pheomelanin: Their Role in Determining the Susceptibility to Skin Cancer , 2015, Photochemistry and photobiology.

[234]  E. Olech,et al.  Adrenocorticotropic hormone gel in the treatment of systemic lupus erythematosus: A retrospective study of patients. , 2015, F1000Research.

[235]  P. Humphries,et al.  The Blood-Retina Barrier , 2013 .

[236]  Darren J. Lee,et al.  Applications of the role of α-MSH in ocular immune privilege. , 2010, Advances in experimental medicine and biology.

[237]  F. Rüschendorf,et al.  Mutations in MRAP, encoding a new interacting partner of the ACTH receptor, cause familial glucocorticoid deficiency type 2 , 2005, Nature Genetics.

[238]  R. Houlston,et al.  Genetic predisposition to ocular melanoma , 1999, Eye.

[239]  E. Larsson,et al.  Immunohistochemical detection of the melanocortin 1 receptor in human testis, ovary and placenta using specific monoclonal antibody. , 1997, Hormone research.